Archive for the ‘biotech/medical’ category: Page 310
Jan 19, 2024
Genome-wide association study identifies 74 loci associated with educational attainment
Posted by Dan Breeden in categories: biotech/medical, education, genetics
A genome-wide association study in 293,723 individuals identifies 74 genetic variants associated with educational attainment, which, although only explaining a small proportion of the variation in educational attainment, highlights candidate genes and pathways for further study.
Jan 19, 2024
The National Science Foundation funds Bruker NMR installation at The Ohio State University
Posted by Dan Breeden in categories: biotech/medical, science
Novel GHz-class NMR systems are enabling unprecedented life science and materials research in functional structural biology, drug discovery, metabolomics, and cleantech research.
Jan 18, 2024
For This Emergent Class of Materials, “Solutions Are the Problem”
Posted by Saúl Morales Rodriguéz in categories: biotech/medical, materials
Rice University materials scientists developed a fast, low-cost, scalable method to make covalent organic frameworks (COFs). Credit: Photo by Gustavo Raskosky/Rice University.
Materials scientists at Rice University have created an efficient, affordable, and scalable technique for producing covalent organic frameworks (COFs). These crystalline polymers are notable for their adjustable molecular structure, extensive surface area, and porosity, making them potentially valuable in areas like energy applications, semiconductor devices, sensors, filtration systems, and drug delivery.
“What makes these structures so special is that they are polymers but they arrange themselves in an ordered, repeating structure that makes it a crystal,” said Jeremy Daum, a Rice doctoral student and lead author of a study published in ACS Nano. “These structures look a bit like chicken wire ⎯ they’re hexagonal lattices that repeat themselves on a two-dimensional plane, and then they stack on top of themselves, and that’s how you get a layered 2D material.”
Jan 18, 2024
Toxic RNAs: The Hidden Cause of Neuron Death in Alzheimer’s Uncovered
Posted by Saúl Morales Rodriguéz in categories: biotech/medical, life extension, neuroscience
A new Northwestern Medicine study shows that RNA interference may play a key role in Alzheimer’s. For the first time, scientists have identified short strands of toxic RNAs that contribute to brain cell death and DNA damage in Alzheimer’s and aged brains. Short strands of protective RNAs are decreased during aging, the scientists report, which may allow Alzheimer’s to develop.
The study also found that older individuals with a superior memory capacity (known as SuperAgers) have higher amounts of protective short RNA strands in their brain cells. SuperAgers are individuals aged 80 and older with a memory capacity of individuals 20 to 30 years younger.
“Nobody has ever connected the activities of RNAs to Alzheimer’s,” said corresponding study author Marcus Peter, the Tom D. Spies Professor of Cancer Metabolism at Northwestern University Feinberg School of Medicine. “We found that in aging brain cells, the balance between toxic and protective sRNAs shifts toward toxic ones.”
Jan 18, 2024
DNA From Ancient Gum Reveals Secrets of Stone Age Dentistry
Posted by Saúl Morales Rodriguéz in categories: biotech/medical, health
Mesolithic Scandinavians likely faced oral health issues, with studies on ancient birch tar revealing signs of gum disease, tooth decay, and diverse dietary habits.
Members of a hunter-gatherer group that lived in south-western Scandinavia during the Mesolithic era — approximately 10,000 years ago — may have been affected by tooth decay and gum disease, according to a study published today (January 18) in Scientific Reports.
DNA Analysis of Birch Tar.
Jan 18, 2024
Unfolding Mysteries: DNA Origami Unveils Hidden Mechanisms of Critical Cell Function
Posted by Saúl Morales Rodriguéz in category: biotech/medical
Researchers at Karolinska Institutet in Sweden have used DNA origami, the art of folding DNA into desired structures, to show how an important cell receptor can be activated in a previously unknown way. The result opens new avenues for understanding how the Notch signaling pathway works and how it is involved in several serious diseases. The study is published in Nature Communications.
Notch is a cell receptor that is of great importance to a wide range of organisms and plays a crucial role in many different processes, including early embryonic development in both flies and humans. Notch regulates the development of stem cells into different cell types in the body. Defects in this signaling pathway can result in serious diseases, including cancer.
The prevailing view of the receptor’s function has so far been that it is activated purely mechanically, by a neighboring cell pulling on it, meaning that signaling only occurs as a result of direct communication between cells.
Jan 18, 2024
These 3 Personality Traits Are Linked to a Lower Risk of Dementia
Posted by Saúl Morales Rodriguéz in categories: biotech/medical, neuroscience
Individuals with personality traits such as conscientiousness, extraversion, and positive affect are less likely to be diagnosed with dementia than those with neuroticism and negative affect, according to a new analysis by researchers at the University of California, Davis, and Northwestern University. The difference was not linked to physical damage to brain tissue found in dementia patients, but more likely to how certain personality traits help people navigate dementia-related impairments.
The work was recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
Previous studies have tried to establish links between personality traits and dementia, but these were mostly small and represented only specific populations, said Emorie Beck, assistant professor of psychology at UC Davis and first author on the paper.
Jan 18, 2024
FDA Approves New CRISPR Gene-Editing Treatment
Posted by Paul Battista in categories: biotech/medical, genetics
The Food and Drug Administration approved the use of Casgevy, a CRISPR gene-editing therapy, for treating the serious blood disorder transfusion-dependent beta thalassemia—the second major approval for the emerging therapy.
Jan 18, 2024
Using A.I. & Blockchain to Target Aging: Kennedy Schaal at EARD 2023
Posted by Montie Adkins in categories: biotech/medical, blockchains, genetics, life extension, robotics/AI
A.I. for longevity and long lived flies.
Kennedy Schaal presents “Using Advanced A.I. and Blockchain Technology to Targey Aging” at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io. Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Kennedy Schaal is the founder and CEO of Rejuve Biotech, an AI-driven therapeutics discovery company solving the problems for longevity and age-associated diseases. By using advanced Artificial Intelligence to combine data from the Methuselah Flies with data from people, Rejuve. Bio can shorten the drug discovery pipeline and rapidly develop novel therapeutics to help people live longer. They have two high-impact and novel data sources, as well as unique artificial intelligence technology. First and foremost, they are the sole owner of data from the Methuselah Flies (fruit flies) that have been bred for longevity. Second, because flies have a shorter life cycle, they can be tested for longevity much faster than other animal models. Rejuve Biotech has the unique ability to test multiple interventions and treatment combinations over the course of a fruit fly’s life and in various aspects of its life (e.g., mating, disease resistance). In addition, they also have quick access to Crowdsourced Human Data collected by a partner company, Rejuve Network. Kennedy Schaal is an accomplished biotechnology executive with a strong leadership track record in applied genomic research and Artificial Intelligence at the frontier of longevity science. She is also a multi-published author on the science of longevity and applied genomics trials. Kennedy is also a world-leading expert on genomic selection and breeding for innovative Drosophila Methuselah Flies, which together with applied Artificial Intelligence solve many of today’s pain points in longevity research, with the potential for massive impact on the health and lifespan of people across the planet. Experienced Laboratory Director and Chief Biologist with a demonstrated history of working in the biotechnology industry. Strong research professional skilled in evolutionary biology, genetics, and the study of aging-related diseases.